Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting
Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDTDEVON, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Zynerba…
Pharmaceuticals, Biotechnology and Life Sciences
Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDTDEVON, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Zynerba…
Montrouge, France, July 25, 2023 DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update DBV…
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics…
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer…
— Spain’s Drug Pricing Committee recommends reimbursement of VAZKEPA® (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in…
WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the “Company” or “Aquestive”), a pharmaceutical company…
— Exceeded Target Enrollment; Expect to Randomize More Than 2,500 Patients — — Topline Results Expected in 2H 2024 –…
Oral Presentation of Cohort 3A Data from IOV-COM-202 Phase 2 Clinical Trial of LN-145 in Combination with Pembrolizumab in Anti-PD1-naïve…
HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused,…
Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of…